![CDK4/6 inhibitor plus endocrine therapy for hormone receptor‐positive, HER2‐negative metastatic breast cancer: The new standard of care - Hui - 2021 - Asia-Pacific Journal of Clinical Oncology - Wiley Online Library CDK4/6 inhibitor plus endocrine therapy for hormone receptor‐positive, HER2‐negative metastatic breast cancer: The new standard of care - Hui - 2021 - Asia-Pacific Journal of Clinical Oncology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/9b49437f-35d0-4948-9b40-d81032414772/ajco.v17.s1.cover.jpg)
CDK4/6 inhibitor plus endocrine therapy for hormone receptor‐positive, HER2‐negative metastatic breast cancer: The new standard of care - Hui - 2021 - Asia-Pacific Journal of Clinical Oncology - Wiley Online Library
![Faculty research evaluates innovative but costly cancer therapy in Journal of Clinical Oncology review article Faculty research evaluates innovative but costly cancer therapy in Journal of Clinical Oncology review article](https://news.cuanschutz.edu/hubfs/Money_banner.png)
Faculty research evaluates innovative but costly cancer therapy in Journal of Clinical Oncology review article
![Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/dace42da-0f5d-4ff4-9fba-d7d92081b7c6/gr1_lrg.jpg)
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology
![Clinical development and potential of photothermal and photodynamic therapies for cancer | Nature Reviews Clinical Oncology Clinical development and potential of photothermal and photodynamic therapies for cancer | Nature Reviews Clinical Oncology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41571-020-0410-2/MediaObjects/41571_2020_410_Fig1_HTML.png)
Clinical development and potential of photothermal and photodynamic therapies for cancer | Nature Reviews Clinical Oncology
Neurotoxic Effects of Childhood Cancer Therapy and Its Potential Neurocognitive Impact | Journal of Clinical Oncology
![Journal of Clinical Oncology - ASCO Pub - Abstract - Pancreatic Cancer and other GI Tumors harboring a KRAS (G12C) Mutation. Alex Spria, MD, PhD, FACP - Virginia Cancer Specialists Journal of Clinical Oncology - ASCO Pub - Abstract - Pancreatic Cancer and other GI Tumors harboring a KRAS (G12C) Mutation. Alex Spria, MD, PhD, FACP - Virginia Cancer Specialists](https://virginiacancerspecialists.com/wp-content/uploads/2022/01/AdobeStock_282277367-pancreatic-cancer-scaled-e1642697608998.jpeg)